Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 1Sanofi Winthrop Industrie Gentilly FR
02 1SCI PHARMTECH, INC. Taoyuan City TW
03 1ANJAN DRUG PRIVATE LIMITED Alathur IN
04 1ASSURGEN PHARMA PVT LTD Lalamkoduru Village IN
05 1DUPONT NUTRITION BIOSCIENCES APS Brabrand DK
06 1HARMAN FINOCHEM LIMITED Mumbai IN
07 2Katwijk Chemie BV Katwijk ZH NL
08 3SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai IN
01 7Sodium valproate
02 1Sodium valproate, Crystals
03 1Sodium valproate, Powder
04 1Sodium valproate, Process II
05 1Sodium valproate, Process III
01 1Denmark
02 1France
03 6India
04 2Netherlands
05 1Taiwan
01 10Valid
02 1Withdrawn by Holder
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Certificate Number : CEP 2004-198 - Rev 05
Status : Valid
Issue Date : 2024-02-06
Type : Chemical
Substance Number : 678
SCI Pharmtech offers high-quality, cost-effective APIs, advanced intermediates, & custom products with global expertise and precision.
SCI Pharmtech offers high-quality, cost-effective APIs, advanced intermediates, & custom products with global expertise and precision.
Certificate Number : R1-CEP 2004-302 - Rev 04
Status : Valid
Issue Date : 2019-07-26
Type : Chemical
Substance Number : 678
Certificate Number : R1-CEP 2003-180 - Rev 03
Status : Valid
Issue Date : 2019-07-02
Type : Chemical
Substance Number : 678
Certificate Number : R0-CEP 2020-373 - Rev 00
Status : Valid
Issue Date : 2021-09-13
Type : Chemical
Substance Number : 678
Certificate Number : CEP 2015-281 - Rev 01
Status : Valid
Issue Date : 2024-09-11
Type : Chemical
Substance Number : 678
Certificate Number : R1-CEP 2004-250 - Rev 01
Status : Valid
Issue Date : 2012-07-05
Type : Chemical
Substance Number : 678
Certificate Number : R1-CEP 1997-021 - Rev 03
Status : Valid
Issue Date : 2008-08-05
Type : Chemical
Substance Number : 678
Certificate Number : R1-CEP 2004-027 - Rev 04
Status : Valid
Issue Date : 2020-12-16
Type : Chemical
Substance Number : 678
Certificate Number : R1-CEP 2014-179 - Rev 01
Status : Valid
Issue Date : 2022-08-17
Type : Chemical
Substance Number : 678
Certificate Number : CEP 2023-252 - Rev 00
Status : Valid
Issue Date : 2023-12-12
Type : Chemical
Substance Number : 678
A Valproate Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Valproate Sodium, including repackagers and relabelers. The FDA regulates Valproate Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Valproate Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Valproate Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Valproate Sodium supplier is an individual or a company that provides Valproate Sodium active pharmaceutical ingredient (API) or Valproate Sodium finished formulations upon request. The Valproate Sodium suppliers may include Valproate Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Valproate Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Valproate Sodium CEP of the European Pharmacopoeia monograph is often referred to as a Valproate Sodium Certificate of Suitability (COS). The purpose of a Valproate Sodium CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Valproate Sodium EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Valproate Sodium to their clients by showing that a Valproate Sodium CEP has been issued for it. The manufacturer submits a Valproate Sodium CEP (COS) as part of the market authorization procedure, and it takes on the role of a Valproate Sodium CEP holder for the record. Additionally, the data presented in the Valproate Sodium CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Valproate Sodium DMF.
A Valproate Sodium CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Valproate Sodium CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Valproate Sodium suppliers with CEP (COS) on PharmaCompass.
We have 8 companies offering Valproate Sodium
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
